Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hedgehog signaling maintains chemoresistance in myeloid leukemic cells

Abstract

The development of resistance against chemotherapy remains one of the major challenges in the clinical management of leukemia. There is still limited insight into the molecular mechanisms that maintain the chemotherapy-resistant phenotype, despite the obvious clinical relevance that such knowledge would have. In this study, we show that the chemotherapy-resistant phenotype of myeloid leukemia cells correlates with activation of the Hedgehog (Hh) pathway, whereas in chemosensitive cells, such activation is less pronounced. Importantly, the overexpression of Hh pathway components induces chemoprotection and inhibition of the pathway reverts chemoresistance of Lucena-1 cells, apparently by interfering with P-glycoprotein-dependent drug resistance. Our data thus identify the Hh pathway as an essential component of multidrug resistance (MDR) myeloid leukemia and suggest that targeting the Hh pathway might be an interesting therapeutic avenue for overcoming MDR resistance in myeloid leukemia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bijlsma MF, Spek CA, Zivkovic D, van de Water S, Rezaee F, Peppelenbosch MP . (2006). Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol 4: e232.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen JK, Taipale J, Cooper MK, Beachy PA . (2002). Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 16: 2743–2748.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dean M . (1997). Towards a unified model of tumor suppression: lessons learned from the human patched gene. Biochim Biophys Acta 1332: 43–52.

    Google Scholar 

  • Dean M, Fojo T, Bates S . (2005). Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275–284.

    Article  CAS  PubMed  Google Scholar 

  • Diehl KM, Keller ET, Ignatoski KM . (2007). Why should we still care about oncogenes? Mol Cancer Ther 6: 418–427.

    Article  CAS  PubMed  Google Scholar 

  • Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P et al. (2008). Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14: 238–249.

    Article  CAS  PubMed  Google Scholar 

  • Hartree EF . (1972). Determination of proteins: a modification of Lowry method that give a linear photometric response. Anal Biochem 48: 422–427.

    Article  CAS  PubMed  Google Scholar 

  • Higgins CF . (2007). Multiple molecular mechanisms for multidrug resistance transporters. Nature 446: 749–757.

    Article  CAS  PubMed  Google Scholar 

  • Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH et al. (2009). Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 4: 559–567.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kobune M, Takimoto R, Murase K, Iyama S, Sato T, Kikuchi S et al. (2009). Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells. Cancer Sci 100: 948–955.

    Article  CAS  PubMed  Google Scholar 

  • Kroemer G, Pouyssegur J . (2008). Tumor cell metabolism: cancer's achilles’ heel. Cancer Cell 13: 472–482.

    Article  CAS  PubMed  Google Scholar 

  • Lauth M, Bergström A, Shimokawa T, Toftgård R . (2007). Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 104: 8455–8460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lauth M, Toftgård R . (2007). The Hedgehog pathway as a drug target in cancer therapy. Curr Opin Investig Drugs 8: 457–461.

    CAS  PubMed  Google Scholar 

  • Löwenberg B . (2007). On the road to new drugs in acute myeloid leukemia. JCO 25: 1–2.

    Article  Google Scholar 

  • Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L et al. (2003). A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia 17: 1794–1805.

    Article  CAS  PubMed  Google Scholar 

  • Mosmann T . (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Meth 65: 55–63.

    Article  CAS  Google Scholar 

  • O'Hare T, Corbin AS, Druker BJ . (2006). Targeted CML therapy: controlling drug resistance, seeking cure. Curr Opin Genet Dev 16: 92–99.

    Article  CAS  PubMed  Google Scholar 

  • Rumjanek VM, Trindade GS, Wagner-Souza K, de-Oliveira MC, Marques-Santos LF, Maia RC et al. (2001). Multidrug resistance in tumor cells: characterisation of the multidrug resistant cell line K562-Lucena 1. Ann Acad Bras Ci 73: 57–69.

    Article  CAS  Google Scholar 

  • Sims-Mourtada J, Izzo JG, Apisarnthanarax S, Wu TT, Malhotra U, Luthra R et al. (2006). Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res 12: 6565–6572.

    Article  CAS  PubMed  Google Scholar 

  • Svärd J, Heby-Henricson K, Persson-Lek M, Rozell B, Lauth M, Bergström A et al. (2006). Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell 10: 187–197.

    Article  PubMed  Google Scholar 

  • Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J et al. (2009). Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458: 776–779.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhao Y, Tong C, Jiang J . (2007). Hedgehog regulates smoothened activity by inducing a conformational switch. Nature 450: 252–258.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

KCS Queiroz is supported by the Maag-, Lever-, Darmstichting. CV Ferreira is supported by a research fellowship from CNPq. MP Peppelenbosch and CA Spek acknowledge the support of the Top-Institute pharma. We are grateful to Professor Vivian Rumjanek (Federal University of Rio de Janeiro) for donating Lucena-1 cells.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K C S Queiroz.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Queiroz, K., Ruela-de-Sousa, R., Fuhler, G. et al. Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene 29, 6314–6322 (2010). https://doi.org/10.1038/onc.2010.375

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.375

Keywords

This article is cited by

Search

Quick links